Casellas-Pujol, E, Soler, J, Schmidt, C, Soria-Madrid, A, Elices, M, Pascual, JC. Contextual-compassion training for borderline personality disorder with long lasting symptoms: A randomized clinical trial. Journal of Contextual Behavioral Science. 2024; 34DOI:10.1016/j.jcbs.2024.100846. PMID:. IF:3.000(Q1/3D).

Bonifacio, DM, Rodríguez, MP, Perelló, PM, Hurtado, JC, Albet, JT, Tutusaus, XR, Arbós, RMA. A pilot, randomized, three-arm, dose-finding, placebo-controlled, parallel study to evaluate the use of nabiximols (THC plus CBD, Sativex^®) for cannabis detoxification treatment versus treatment as usual. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).

Cano, A, Capdevila, M, Puerta, R, Arranz, J, Montrreal, L, de Rojas, I, García-González, P, Olivé, C, García-Gutiérrez, F, Sotolongo-Grau, O, Orellana, A, Aguilera, N, Ramis, M, Rosende-Roca, M, Lleó, A, Fortea, J, Tartari, JP, Lafuente, A, Vargas, L, Pérez-Cordón, A, Muñoz, N, Sanabria, A, Alegret, M, Morató, X, Tárraga, L, Fernández, V, Marquié, M, Valero, S, Alcolea, D, Boada, M, Ruiz, A. Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105345. PMID:39299003. IF:10.800(Q1/1D).

Pascoal, TA, Aguzzoli, CS, Lussier, FZ, Crivelli, L, Suemoto, CK, Fortea, J, Rosa-Neto, P, Zimmer, ER, Ferreira, PCL, Bellaver, B. Insights into the use of biomarkers in clinical trials in Alzheimer's ' s disease. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105322. PMID:39366844. IF:10.800(Q1/1D).